2013 Q1 Form 10-Q Financial Statement

#000115752313002558 Filed on May 09, 2013

View on sec.gov

Income Statement

Concept 2013 Q1 2012 Q1
Revenue $83.84M $75.82M
YoY Change 10.57% 29.25%
Cost Of Revenue $28.41M $27.85M
YoY Change 2.01% 25.96%
Gross Profit $55.44M $47.97M
YoY Change 15.57% 31.21%
Gross Profit Margin 66.13% 63.27%
Selling, General & Admin $34.02M $30.44M
YoY Change 11.74% 42.26%
% of Gross Profit 61.36% 63.46%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.210M $2.660M
YoY Change 20.68% 27.27%
% of Gross Profit 5.79% 5.55%
Operating Expenses $34.02M $30.44M
YoY Change 11.74% 29.66%
Operating Profit $18.21M $14.89M
YoY Change 22.29% 13.69%
Interest Expense $64.00K $20.00K
YoY Change 220.0% -33.33%
% of Operating Profit 0.35% 0.13%
Other Income/Expense, Net
YoY Change
Pretax Income $18.27M $14.89M
YoY Change 22.72% 13.67%
Income Tax $6.850M $5.808M
% Of Pretax Income 37.48% 39.0%
Net Earnings $11.38M $9.083M
YoY Change 25.24% 15.6%
Net Earnings / Revenue 13.57% 11.98%
Basic Earnings Per Share $0.64 $0.51
Diluted Earnings Per Share $0.63 $0.50
COMMON SHARES
Basic Shares Outstanding 17.76M shares 17.85M shares
Diluted Shares Outstanding 18.00M shares 18.23M shares

Balance Sheet

Concept 2013 Q1 2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $120.6M $125.8M
YoY Change -4.13% 30.36%
Cash & Equivalents $120.6M $125.8M
Short-Term Investments
Other Short-Term Assets $10.20M $9.700M
YoY Change 5.15% 53.97%
Inventory
Prepaid Expenses $5.056M
Receivables $12.21M $9.100M
Other Receivables $400.0K $0.00
Total Short-Term Assets $143.3M $144.6M
YoY Change -0.89% 28.42%
LONG-TERM ASSETS
Property, Plant & Equipment $85.61M $62.80M
YoY Change 36.32% 42.08%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $10.62M
YoY Change
Other Assets $1.201M $1.400M
YoY Change -14.21% -12.5%
Total Long-Term Assets $103.4M $64.20M
YoY Change 61.1% 40.17%
TOTAL ASSETS
Total Short-Term Assets $143.3M $144.6M
Total Long-Term Assets $103.4M $64.20M
Total Assets $246.7M $208.8M
YoY Change 18.17% 31.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $15.25M $13.30M
YoY Change 14.64% 30.39%
Accrued Expenses $11.66M $14.80M
YoY Change -21.24% 57.45%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $55.98M $56.80M
YoY Change -1.45% 22.15%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $55.98M $56.80M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $68.09M $66.20M
YoY Change 2.85% 23.97%
SHAREHOLDERS EQUITY
Retained Earnings $19.91M
YoY Change
Common Stock $158.7M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $178.7M $142.6M
YoY Change
Total Liabilities & Shareholders Equity $246.7M $208.8M
YoY Change 18.17% 31.82%

Cashflow Statement

Concept 2013 Q1 2012 Q1
OPERATING ACTIVITIES
Net Income $11.38M $9.083M
YoY Change 25.24% 15.6%
Depreciation, Depletion And Amortization $3.210M $2.660M
YoY Change 20.68% 27.27%
Cash From Operating Activities $20.60M $14.85M
YoY Change 38.75% -25.31%
INVESTING ACTIVITIES
Capital Expenditures $5.947M $6.577M
YoY Change -9.58% -279.7%
Acquisitions
YoY Change
Other Investing Activities $88.00K $109.0K
YoY Change -19.27%
Cash From Investing Activities -$10.04M -$6.686M
YoY Change 50.09% 82.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $5.770M $3.857M
YoY Change 49.6%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -4.919M -1.343M
YoY Change 266.27% 29.13%
NET CHANGE
Cash From Operating Activities 20.60M 14.85M
Cash From Investing Activities -10.04M -6.686M
Cash From Financing Activities -4.919M -1.343M
Net Change In Cash 5.649M 6.820M
YoY Change -17.17% -55.07%
FREE CASH FLOW
Cash From Operating Activities $20.60M $14.85M
Capital Expenditures $5.947M $6.577M
Free Cash Flow $14.66M $8.272M
YoY Change 77.18% -64.86%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q1 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.216 pure
CY2013Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
17605132 shares
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
125826000
CY2013Q1 us-gaap Equity Method Investments
EquityMethodInvestments
10616000
CY2013Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
5113000
CY2013Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
158561000
CY2013Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1201000
CY2013Q1 us-gaap Stockholders Equity
StockholdersEquity
178650000
CY2013Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
7200000
CY2013Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17667000 shares
CY2013Q1 us-gaap Liabilities
Liabilities
68090000
CY2013Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
15247000
CY2013Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5056000
CY2013Q1 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
6000000
CY2013Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2013Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
386000
CY2013Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
19912000
CY2013Q1 us-gaap Assets
Assets
246740000
CY2013Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
12113000
CY2013Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12211000
CY2013Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
246740000
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
120550000
CY2013Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17667000 shares
CY2013Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11657000
CY2013Q1 us-gaap Liabilities Current
LiabilitiesCurrent
55977000
CY2013Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
9425000
CY2013Q1 us-gaap Common Stock Value
CommonStockValue
177000
CY2013Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q1 us-gaap Assets Current
AssetsCurrent
143316000
CY2013Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2013Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2013Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
85607000
CY2013Q1 apei Deferred Revenue And Student Deposits
DeferredRevenueAndStudentDeposits
29073000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
119006000
CY2012Q4 us-gaap Equity Method Investments
EquityMethodInvestments
6664000
CY2012Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
6502000
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
157449000
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1025000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
171153000
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17752000 shares
CY2012Q4 us-gaap Liabilities
Liabilities
66450000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
17251000
CY2012Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4290000
CY2012Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
6000000
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2012Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
4953000
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
13526000
CY2012Q4 us-gaap Assets
Assets
237603000
CY2012Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
11380000
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10428000
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
237603000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
114901000
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17752000 shares
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12042000
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
55070000
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
11106000
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
178000
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Assets Current
AssetsCurrent
141074000
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
82840000
CY2012Q4 apei Deferred Revenue And Student Deposits
DeferredRevenueAndStudentDeposits
25777000
CY2013Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
4000000
CY2013Q1 dei Trading Symbol
TradingSymbol
APEI
CY2013Q1 dei Entity Registrant Name
EntityRegistrantName
AMERICAN PUBLIC EDUCATION INC
CY2013Q1 dei Amendment Flag
AmendmentFlag
false
CY2013Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2013Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2013Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013Q1 dei Document Type
DocumentType
10-Q
CY2013Q1 dei Document Period End Date
DocumentPeriodEndDate
2013-03-31
CY2013Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001201792
CY2013Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013Q1 us-gaap Costs And Expenses
CostsAndExpenses
65630000
CY2013Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
4000000
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
18210000
CY2013Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
402000
CY2013Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2004000
CY2013Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-59000
CY2013Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
-48000
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.63
CY2013Q1 us-gaap Investment Income Net
InvestmentIncomeNet
-48000
CY2013Q1 us-gaap Basis Of Accounting
BasisOfAccounting
<div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> 2. Basis of Presentation</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#xA0;</font></div> <div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The accompanying unaudited interim consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States (&#x201C;GAAP&#x201D;).&#xA0;&#xA0;All intercompany transactions have been eliminated in consolidation.&#xA0;&#xA0;The financial statements do not include all of the information and footnotes required by GAAP for complete financial statement presentations. In the opinion of management, these statements include all adjustments (consisting of normal recurring adjustments) considered necessary to present a fair statement of our consolidated results of operations, financial position and cash flows. Operating results for any interim period are not necessarily indicative of the results that may be expected for the year ending December&#xA0;31, 2013. This Quarterly Report on Form 10-Q should be read in conjunction with the Company&#x2019;s consolidated financial statements and footnotes in its audited financial statements included in its Annual Report, on Form 10-K, for the year ended December&#xA0;31, 2012.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#xA0;</font></div> <div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> Use of Estimates</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> Recent Accounting Pronouncements</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#xA0;</font></div> <div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> There have been no applicable pronouncements since our last filing.</font></font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><br /> </font></div> <div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> Investments</font></font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><br /> </font></div> <div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> On September 30, 2012, the Company made a $6.8 million or approximately 19.9% investment in preferred stock of NWHW Holdings, Inc. (&#x201C;NWHW Holdings&#x201D;), which in turn acquired New Horizons Worldwide, Inc. ("New Horizons"). New Horizons is a global IT training company operating in approximately 260 locations around the world through franchise arrangements in 41 states and 63 countries. In connection with the investment, APEI is entitled to certain rights, including right to representation on the Board of Directors of NWHW Holdings. The Company recorded the investment at cost and will recognize its share of earnings or losses in the investee in the periods for which they are reported with a corresponding adjustment in the carrying amount of the investment.</font></font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><br /> </font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> On February 20, 2013, the Company made a $4.0 million investment in preferred stock of Fidelis Education,&#xA0;&#xA0;Inc. (&#x201C;Fidelis Education&#x201D;), representing approximately 21.6% of its fully diluted equity. Fidelis Education is developing a technology platform&#xA0;to assist working adult students with education advising and career mentoring services as they pursue college degrees.&#xA0; In connection with the investment, APEI is entitled to certain rights, including right to representation on the Board of Directors. The Company recorded the investment at cost and will recognize its share of earnings or losses in the investee in the periods for which they are reported with a corresponding adjustment in the carrying amount of the investment.</font></font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><br /> </font></div> <div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> Note Receivable</font></font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><br /> </font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> In connection with the Company's minority investment in NWHW Holdings, the Company extended $6.0 million in credit to New Horizons in exchange for a subordinated note. The note matures on September 28, 2018, with monthly interest payments of 5.0% per annum during the first five years of the note and interest payments of 6.0% per annum in the sixth year. We evaluate the loan receivable by analyzing the borrower's creditworthiness, cash flows and financial status, and the condition and estimated value of the collateral. We consider a loan to be impaired when, based upon current information and events, we believe it is probable that we will be unable to collect all amounts due according to the contractual terms of the loan agreement.</font></font></div> &#xA0;</div> <div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold"> Commitments and</font> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">Contingencies</font></font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#xA0;</font></div> <div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company accrues for costs associated with contingencies including, but not limited to, regulatory compliance and legal matters when such costs are probable and can be reasonably estimated. Liabilities established to provide for contingencies are adjusted as further information develops, circumstances change, or contingencies are resolved. The Company bases these accruals on management&#x2019;s estimate of such costs, which may vary from the ultimate cost and expenses associated with any such contingency.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#xA0;</font></div> <div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">From time to time, the Company may be involved in litigation in the normal course of its business.&#xA0;&#xA0;The Company is not aware of any pending or threatened litigation matters that, in the opinion of management, will have a material adverse effect on the Company&#x2019;s business, operations, financial condition or cash flows.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#xA0;&#xA0;&#xA0;&#xA0;</font></div> <div style="TEXT-INDENT: 9pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> Concentration</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div> <div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Approximately 39%&#xA0;&#xA0;of the Company&#x2019;s revenues for the three-month period ended March&#xA0;31, 2013 were derived from students who received tuition assistance from tuition assistance programs sponsored by the United States Department of Defense (&#x201C;DoD&#x201D;) compared to approximately 40% of the Company&#x2019;s revenues for the three months ended March&#xA0;31, 2012. Approximately 15%&#xA0;of the Company&#x2019;s revenues for the three-month period ended March&#xA0;31, 2013 were derived from students who were eligible for veterans benefits compared to approximately 12% of the Company&#x2019;s revenues for the three months ended March&#xA0;31, 2012. Approximately 35% of the Company&#x2019;s revenues for the three months ended March&#xA0;31, 2013, were from students using financial aid under the Title IV programs compared to 34% for the three months ended March&#xA0;31, 2012. A reduction in any of these programs or a change in maximum benefits allowed to students thereunder could have a significant impact on the Company&#x2019;s operations.</font></div> </div>
CY2013Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
5770000
CY2013Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
79000
CY2013Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-4567000
CY2013Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3207000
CY2013Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
769000
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
20603000
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10035000
CY2013Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5947000
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
5649000
CY2013Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17479000
CY2013Q1 us-gaap Increase Decrease In Deferred Revenue And Customer Advances And Deposits
IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits
3296000
CY2013Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
940000
CY2013Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17999961 shares
CY2013Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
102000
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
18274000
CY2013Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
16539000
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.64
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4919000
CY2013Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
64000
CY2013Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
613000
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17764330 shares
CY2012Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3857000
CY2013Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
83840000
CY2013Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
88000
CY2013Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1015000
CY2013Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2122000
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
11376000
CY2013Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
82000
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6850000
CY2013Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-385000
CY2013Q1 apei Other Stock Based Compensation Expense
OtherStockBasedCompensationExpense
25000
CY2013Q1 apei Instructional Costs And Expenses
InstructionalCostsAndExpenses
28405000
CY2013Q1 apei Share Based Compensation Excluding Director Incentive Shares
ShareBasedCompensationExcludingDirectorIncentiveShares
1015000
CY2013Q1 apei Increase Decrease In Allowance For Doubtful Accounts
IncreaseDecreaseInAllowanceForDoubtfulAccounts
-1681000
CY2012Q1 us-gaap Costs And Expenses
CostsAndExpenses
60952000
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
14870000
CY2012Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
401000
CY2012Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3063000
CY2012Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.50
CY2012Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-1603000
CY2012Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2656000
CY2012Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
767000
CY2012Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
14849000
CY2012Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6686000
CY2012Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
257000
CY2012Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6577000
CY2012Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
6820000
CY2012Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16072000
CY2012Q1 us-gaap Increase Decrease In Deferred Revenue And Customer Advances And Deposits
IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits
1194000
CY2012Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
571000
CY2012Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18233669 shares
CY2012Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1601000
CY2012Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
14891000
CY2012Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
14371000
CY2012Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.51
CY2012Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1343000
CY2012Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
21000
CY2012Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
613000
CY2012Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17854114 shares
CY2012Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
75822000
CY2012Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
109000
CY2012Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1014000
CY2012Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
512000
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
9083000
CY2012Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1747000
CY2012Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5808000
CY2012Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
294000
CY2012Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
1688000
CY2012Q1 apei Other Stock Based Compensation Expense
OtherStockBasedCompensationExpense
33000
CY2012Q1 apei Instructional Costs And Expenses
InstructionalCostsAndExpenses
27853000
CY2012Q1 apei Share Based Compensation Excluding Director Incentive Shares
ShareBasedCompensationExcludingDirectorIncentiveShares
1014000
CY2012Q1 apei Increase Decrease In Allowance For Doubtful Accounts
IncreaseDecreaseInAllowanceForDoubtfulAccounts
2007000

Files In Submission

Name View Source Status
0001157523-13-002558-index-headers.html Edgar Link pending
0001157523-13-002558-index.html Edgar Link pending
0001157523-13-002558.txt Edgar Link pending
0001157523-13-002558-xbrl.zip Edgar Link pending
a50626554.htm Edgar Link pending
a50626554ex31-01.htm Edgar Link pending
a50626554ex31-02.htm Edgar Link pending
a50626554ex32-01.htm Edgar Link pending
apei-20130331.xml Edgar Link completed
apei-20130331.xsd Edgar Link pending
apei-20130331_cal.xml Edgar Link unprocessable
apei-20130331_def.xml Edgar Link unprocessable
apei-20130331_lab.xml Edgar Link unprocessable
apei-20130331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending